Clinical Usefulness of Novel Serum and Imaging Biomarkers in Risk Stratification of Patients with Stable Angina

<table>Schematic approach of the current established mechanisms in stable angina pathophysiology (LV: left ventricle; LV-EDP: left ventricular end-diastolic pressure; LV-EDV: left ventricular end-diastolic volume).</table>

Disease Markers

fig3

Figure 3

Figure 3: Clinical Usefulness of Novel Serum and Imaging Biomarkers in Risk Stratification of Patients with Stable Angina 